Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Partial Purification of Osteoclast-Activating Factor from Phytohemagglutinin-Stimulated Human Leukocytes
Richard A. Luben, … , Clarence L. Trummel, Lawrence G. Raisz
Richard A. Luben, … , Clarence L. Trummel, Lawrence G. Raisz
Published May 1, 1974
Citation Information: J Clin Invest. 1974;53(5):1473-1480. https://doi.org/10.1172/JCI107696.
View: Text | PDF
Research Article

Partial Purification of Osteoclast-Activating Factor from Phytohemagglutinin-Stimulated Human Leukocytes

  • Text
  • PDF
Abstract

Osteoclast-activating factor (OAF) is a soluble mediator found in supernates of human peripheral leukocytes which have been cultured with antigens or phytomitogens. OAF is a potent stimulator of osteoclastic resorption of fetal bone in organ culture. The present studies were designed to characterize OAF chemically. Bone resorbing activity from supernates of leukocytes cultured without added plasma was not lost on dialysis using a membrane with a molecular weight cutoff of 3,500, but was lost when heated to 60°C for 30 min. The activity was lost after treatment with trypsin or pronase but not after treatment with ribonuclease or neuraminidase. Papain, which inactivated parathyroid hormone at a concentration of 25 μg/ml, did not inactivate OAF at 250 μg/ml. OAF did not react with an antibody to bovine parathyroid hormone which cross-reacts with human parathyroid hormone. OAF was also distinguished from active metabolites of vitamin D and from prostaglandin by extraction procedures and immunoassay for prostaglandin E2.

Authors

Richard A. Luben, Gregory R. Mundy, Clarence L. Trummel, Lawrence G. Raisz

×

Total citations by year

Year: 2024 2014 2011 1999 1994 1992 1990 1989 1988 1987 1986 1985 1984 1983 1982 1981 1980 1979 1978 1977 1976 1975 1974 Total
Citations: 1 1 1 1 1 2 3 2 3 1 3 1 2 3 4 6 7 5 8 6 6 4 2 73
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (73)

Title and authors Publication Year
Facing stress and inflammation: From the cell to the planet
Cavaillon JM, Chaudry IH
World Journal of Experimental Medicine 2024
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes
2014
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné
Advances in Immunology Volume 110 2011
Bone and Cytokines: Beyond IL-1, IL-6 and TNF-α
A Rifas
Calcified Tissue International 1999
Platelet-derived growth factor in middle ear cholesteatoma
O Fujioka, CC Huang
European Archives of Oto-Rhino-Laryngology 1994
Leukemia inhibitory factor (LIF): A growth factor with pleiotropic effects on bone biology
PV Vlasselaer
Progress in Growth Factor Research 1992
Knochenersatzmittel
JM Rueger
1992
Induction of bone resorbing activity by normal and rheumatoid arthritis T cells
E Flescher, IR Garrett, GR Mundy, N Talal
Clinical Immunology and Immunopathology 1990
Cytokines and Osteoporosis
T Fujita, T Matsui, Y Nakao, S Shiozawa, Y Imai
Annals of the New York Academy of Sciences 1990
Interleukin 1 Causing Bone Destruction in Middle Ear Cholesteatoma
JM Ahn, CC Huang, M Abramson
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1990
The metabolism and immunology of bone
DA Watrous, BS Andrews
Seminars in Arthritis and Rheumatism 1989
Osteoclasts and Bone Remodeling in Chronic Myeloproliferative Disorders
J Thiele, B Hoeppner, S Wienhold, G Schneider, R Fischer, R Zankovich
Pathology - Research and Practice 1989
Osteoclast activating factor is now interleukin-1 beta: historical perspective and biological implications
JJ Jandinski
Journal of Oral Pathology and Medicine 1988
Differentiation of plasma cell infiltrates in the bone marrow: A clinicopathological study on 80 patients including immunohistochemistry and morphometry
J Thiele, B Arenz, H Klein, M Vierbuchen, R Zankovich, R Fischer
Virchows Archiv A Pathological Anatomy and Histopathology 1988
Calcium in Human Biology
BE Nordin
1988
Response of osteoblastic clonal cell line (MC3T3-E1) to [Asu1,7]Eel calcitonin at a specific cell density or differentiation stage
N Ito, H Yamazaki, M Nakazaki, T Miyahara, H Kozuka, H Sudo
Calcified Tissue International 1987
Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors
DR Bertolini, GE Nedwin, TS Bringman, DD Smith, GR Mundy
Nature 1986
Advances in understanding cell interactions in tissue resorption. Relevance to the pathogenesis of periodontal diseases and a new hypothesis
MC Meikle, JK Heath, JJ Reynolds
Journal of Oral Pathology and Medicine 1986
Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption
E Abe, H Tanaka, Y Ishimi, C Miyaura, T Hayashi, H Nagasawa, M Tomida, Y Yamaguchi, M Hozumi, T Suda
Proceedings of the National Academy of Sciences 1986
Inflammatory and immunological aspects of the pathogenesis of human periapical lesions
M Torabinejad, WC Eby, IJ Naidorf
Journal of Endodontics 1985
Caribbean T-cell lymphoma/leukemia
SH Swerdlow, JA Habeshaw, AZ Rohatiner, TA Lister, AG Stansfeld
Cancer 1984
Thymus-derived lymphocytes and their interactions with macrophages are required for the production of osteoclast-activating factor in the mouse
M Horowitz, A Vignery, RK Gershon, R Baron
Proceedings of the National Academy of Sciences 1984
Hypercalc�mie bei malignen Erkrankungen
E Heidbreder, K Schafferhans, A Heidland
Klinische Wochenschrift 1983
1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism
E Abe, C Miyaura, H Tanaka, Y Shiina, T Kuribayashi, S Suda, Y Nishii, HF DeLuca, T Suda
Proceedings of the National Academy of Sciences 1983
Spread of prostatic cancer to bone
SC Jacobs
Urology 1983
Modulation of chondrocyte synthesis by lymphokine-rich conditioned media
JH Herman, RC Khosla, CS Mowery, AM Appel
Arthritis & Rheumatism 1982
The hypercalcemia of malignancy: Pathogenesis and management
GR Mundy, TJ Martin
Metabolism 1982
Multiples Myelom
H Ludwig
1982
Purification and partial characterization of a protein from cancer ascites fluid which stimulates the resorption of bone explants in vitro
RB Nimberg, DE Humphries, WS Lloyd, H Wells, K Schmid
The Journal of biological chemistry 1982
Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor
RG Josse, TM Murray, GR Mundy, D Jez, JN Heersche
Journal of Clinical Investigation 1981
Protein synthesis in rheumatoid synovial tissue
JD Smiley, WL Hoffman
Springer Seminars in Immunopathology 1981
Human parathyroid hormone 1-34-mediated hypercalcemia in a rat model, and its inhibition by dichloromethane diphosphonate
SH Doppelt, RM Neer, JT Potts
Calcified Tissue International 1981
Relation of Osteoclast Activating Factor Production to Extent of Bone Disease in Multiple Myeloma
BG Durie, SE Salmon, GR Mundy
British Journal of Haematology 1981
Primary squamous cell carcinoma of the thyroid associated with marked leukocytosis and hypercalcemia
K Saito, Y Kuratomi, K Yamamoto, T Saito, T Kuzuya, S Yoshida, SI Moriyama, A Takahashi
Cancer 1981
Lymphokine-mediated bone resorption requires endogenous prostaglandin synthesis
RS Bockman, MA Repo
Journal of Experimental Medicine 1981
Demonstration and preliminary characterization of bone resorbing activity in freeze-dried gingiva of dogs
RM Hopps, K Nuki, LG Raisz
Calcified Tissue International 1980
Effects of a bone resorptive factor from human cancer ascites fluid on rat bone cell calcium and cyclic AMP
R Dziak, YW Chang, D Humphries, W Lloyd, H Wells, K Schmid, RB Nimberg
Calcified Tissue International 1980
Skeletal Scintigraphy with Technetium Diphosphonate in Multiple Myeloma-a Comparison with Skeletal X-Ray
E Lindström, FD Lindström
Acta Medica Scandinavica 1980
Cell-mediated immunity to collagen and collagen α chains in rheumatoid arthritis and other rheumatic diseases
JM Stuart, AE Postlethwaite, AS Townes, AH Kang
The American Journal of Medicine 1980
Progress in Myeloma
M Vrana, PA Bunn
Progress in Myeloma 1980
An assay for osteoclast-activating factor (OAF) in biological fluids: Detection of OAF in the serum of myeloma patients
RA Luben
Cellular Immunology 1980
Hypercalcaemia in malignant lymphoma
M Greaves, BW Hancock
Postgraduate medical journal 1980
Production of hybridomas secreting monoclonal antibodies against the lympholine osteoclast activating factor
RA Luben, MA Mohler, GE Nedwin
Journal of Clinical Investigation 1979
Effects of osteoclast activating factor from human lymphocytes on cyclic AMP concentrations in isolated mouse bone and bone cells
RA Luben, MC Chen, DM Rosen, MA Mohler
Calcified Tissue International 1979
Partial purification of a bone-resorbing factor elaborated from human allogeneic cultures
JE Horton, WJ Koopman, JJ Farrar, J Fuller-Bonar, SE Mergenhagen
Cellular Immunology 1979
Skeletal Research: an Experimental Approach
EA Tonna
Skeletal Research: an Experimental Approach 1979
The Hypercalcemia of Genitourinary Malignancy
JD Lubensky, MP Gangai
The Journal of Urology 1979
A bone resorbing substance from bovine serum albumin (brA)
PH Stern, JC Miller, SF Chen, DJ Kahn
Calcified Tissue Research 1978
Mechanisms of hypercalcemia in malignancy
A Besarab, JF Caro
Cancer 1978
Primary hyperparathyroidism and chronic lymphocytic leukemia
JC Wang, W Steier, MK Aung, MS Tobin
Cancer 1978
The pathophysiology and clinical aspects of hypercalcemic disorders
DB Lee, ET Zawada, CR Kleeman
The Western journal of medicine 1978
Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia
GR Mundy, ME Rick, R Turcotte, MA Kowalski
The American Journal of Medicine 1978
Hypercalcemic crisis associated with the hypereosinophilic syndrome
JE Gittman, G Schneider, RE Carnes, YS Arkel
The American Journal of Medicine 1978
Purification of a lymphokine: Osteoclast activating factor from human tonsil lymphocytes
RA Luben
Biochemical and Biophysical Research Communications 1978
Calcium Urolithiasis
CY Pak
1978
Big and Little Forms of Osteoclast Activating Factor
GR Mundy, LG Raisz, JL Shapiro, JG Bandelin, RJ Turcotte
Journal of Clinical Investigation 1977
Phytomitogen-induced, lymphokine-mediated cartilage proteoglycan degradation
JH Herman, DS Musgrave, MV Dennis
Arthritis & Rheumatism 1977
Studies on congenital osteopetrosis in microphthalmic mice using organ cultures: impairment of bone resorption in response to physiologic stimulators
LG Raisz, HA Simmons, SC Gworek, G Eilon
Journal of Experimental Medicine 1977
Studies on the pathogenesis of cancer hypercalcemia
WP Myers, R Bockman
Transactions of the American Clinical and Climatological Association 1977
Acute myelofibrosis and malignant hypercalcemia
JA Libnoch, K Ajlouni, WL Millman, AR Guansing, GB Theil
The American Journal of Medicine 1977
Metabolic Bone Disease
OL Bijvoet
Metabolic Bone Disease 1977
Production of osteoclast-activating factor by normal human peripheral blood rosetting and nonrosetting lymphocytes
P Chen, C Trummel, J Horton, JJ Baker, JJ Oppenheim
European Journal of Immunology 1976
Recent insights into the pathogenesis of the proliferative lesion in rheumatoid arthritis
ED Harris
Arthritis & Rheumatism 1976
Human breast tumour-induced osteolysis and prostaglandins
M Dowsett, GC Easty, TJ Powles, DM Easty, AM Neville
Prostaglandins 1976
Serum parathyroid hormone levels and serum calcium levels from birth to senescence
BS Roof, CF Piel, J Hansen, HH Fudenberg
Mechanisms of Ageing and Development 1976
Hypercalcemia and Malignancy
DA Heath
Annals of Clinical Biochemistry 1976
The Year in Endocrinology, 1975–1976
SH Ingbar
1976
Effect of osteoclast activating factor from human leukocytes on bone metabolism
LG Raisz, RA Luben, GR Mundy, JW Dietrich, JE Horton, CL Trummel
Journal of Clinical Investigation 1975
LYMPHOKINES IN RHEUMATOID SYNOVITIS
P Stastny, M Rosenthal, M Andreis, D Cooke, M Ziff
Annals of the New York Academy of Sciences 1975
THE ROLE OF LYMPHOCYTES AND MACROPHAGES IN THE DESTRUCTION OF BONE AND COLLAGEN
SE Mergenhagen, SM Wahl, LM Wahl, JE Horton, LG Raisz
Annals of the New York Academy of Sciences 1975
Hypercalcaemia in Chronic Lymphatic Leukaemia
K Norrby, O Vikrot
Scandinavian Journal of Haematology 1975
Evidence for the Secretion of an Osteoclast Stimulating Factor in Myeloma
GR Mundy, LG Raisz, RA Cooper, GP Schechter, SE Salmon
New England Journal of Medicine 1974
Osteoclastic Bone Resorption and the Hypercalcemia of Cancer
HB Brewer
New England Journal of Medicine 1974

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts